International Immunopharmacology

Aims & Scope

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology.

Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders. • Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. • Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action. • Agents that activate genes or modify transcription and translation within the immune response. • Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active. • Production, function and regulation of cytokines and their receptors. • Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.7
2024	4.80

Journal Rank

Year	Value
2024	3369

Journal Citation Indicator

Year	Value
2024	18703

SJR (SCImago Journal Rank)

Year	Value
2024	1.239

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	155

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• THP-1 cell line: An in vitro cell model for immune modulation approach

  Citation: 1083

  Authors: Wasaporn, Jurriaan J., Harry J.

• Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors

  Citation: 1024

  Authors: Kristian M., Coleman E., Corey J.

• Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential

  Citation: 1018

  Authors: Igor A., Mark T.

• The role of JAK/STAT signaling pathway and its inhibitors in diseases

  Citation: 756

  Authors: Ping, Xiaoyun, Chengjie, Shuang, Youzhi, Xuegang, Hongxing, Donghua, Shiqin

• Nitric oxide in immunity and inflammation

  Citation: 753

  Authors: John W.

• The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients

  Citation: 731

  Authors: Ai-Ping, Jian-ping, Wen-qiang, Hui-ming

• Breast cancer: Biology, biomarkers, and treatments

  Citation: 668

  Authors: Khadijeh, Jafar, Zeinab, Aysooda, Mohammad Hossein, Shima, Elahe, Leila

• MCP-1: Function, regulation, and involvement in disease

  Citation: 621

  Authors: Sanjiv, D., V.

• Neutrophil cell surface receptors and their intracellular signal transduction pathways

  Citation: 541

  Authors: Krisztina, Szabina, Attila

• Immunomodulatory and therapeutic properties of the Nigella sativa L. seed

  Citation: 525

  Authors: Mohamed Labib

---